US 10047122
Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use
granted A61KA61K38/005
Quick answer
US patent 10047122 (Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 14 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K38/005